WCN26-4857 PROSPECTIVE COHORT EVALUATING EFFICACY OF HA-130 HEMOPERFUSION IN REDUCING CHRONIC KIDNEY DISEASE–ASSOCIATED PRURITUS AMONG MAINTENANCE HEMODIALYSIS PATIENTS IN AN OUTPATIENT DIALYSIS SETTING

Read full text Summarise with VIRAT
Authors: ALBERT JOSEPH ARANZA, Ricardo Francisco
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease–associated pruritus (CKD-aP) is a distressing and underrecognized complication among patients receiving maintenance hemodialysis (HD). It significantly diminishes quality of life and increases morbidity. Despite its high prevalence, conventional treatments such as emollients, gabapentinoids, antihistamines, and ultraviolet light therapy often provide limited relief. The condition’s multifactorial pathophysiology involves systemic inflammation, hyperphosphatemia, and the accumulation of uremic toxins, necessitating alternative therapeutic approaches.

Fields of Study & Subjects

Dialysis and Renal Disease Management Parathyroid Disorders and Treatments Dermatology and Skin Diseases

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105252–105252
Publication date
25 March 2026
Language
EN